Clearance of IND and CTA applications in the US and UK for STP938 for the treatment of T cell and B cell lymphomas First-in-class targeted therapy with potential applications in multiple cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback